Last 12 months
Inside the activity.
1 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 25, 2021 Filed May 27, 2021 20:07 UTC |
Fernandes PrabhavathiDirector
|
Exercise / conversionCommon Stock | 14,000 | $1.83 | $25,620.00 |
DisclosureSEC source: 0001192482-21-000463 · edgar.xml · nonDerivative · entry 3 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:07 UTC |
Fernandes PrabhavathiDirector
|
SaleCommon Stock | 19,500 | $8.21 | $160,095.00 |
DisclosureSEC source: 0001192482-21-000463 · edgar.xml · nonDerivative · entry 2 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.19 to $8.23. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 25, 2021 Filed May 27, 2021 20:07 UTC |
Fernandes PrabhavathiDirector
|
Exercise / conversionCommon Stock | 19,500 | $0.28 | $5,460.00 |
DisclosureSEC source: 0001192482-21-000463 · edgar.xml · nonDerivative · entry 1 Fernandes Prabhavathi · CIK 0001540883 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2021 Filed May 14, 2021 20:58 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 31,000 | $0.00 Strike: $0.34 | $0.00 |
DisclosureSEC source: 0001192482-21-000423 · edgar.xml · derivative · entry 3 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,256 Underlying: Common Stock · 31,000 shares Expires 2030-05-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, initially representing a right to purchase a total of 369,256 shares, vests and becomes exercisable in equal annual installments over a three year period, commencing on May 5, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 14, 2021 Filed May 14, 2021 20:58 UTC |
Subramanian SanjayChief Financial Officer
|
SaleCommon Stock | 31,000 | $8.18 | $253,673.00 |
DisclosureSEC source: 0001192482-21-000423 · edgar.xml · nonDerivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.15 to $8.24. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 14, 2021 Filed May 14, 2021 20:58 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 31,000 | $0.34 | $10,540.00 |
DisclosureSEC source: 0001192482-21-000423 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 2,311 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · derivative · entry 12 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,578 Underlying: Common Stock · 2,311 shares Expires 2030-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option, initially representing a right to purchase a total of 50,000 shares, vests and becomes exercisable in equal monthly installments over three years commencing on September 14, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 6,500 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · derivative · entry 11 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,261 Underlying: Common Stock · 6,500 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The option, initially representing a right to purchase a total of 77,641 shares, vests and becomes exercisable annually in equal installments over three years commencing on January 2, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · derivative · entry 10 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,191 Underlying: Common Stock · 2,000 shares Expires 2026-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All of the options became exerciable immediately upon grant. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 4,900 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · derivative · entry 9 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,900 shares Expires 2024-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: All of the options became exerciable immediately upon grant. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 2,311 | $13.81 | $31,914.91 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 8 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 2,311 | $0.57 | $1,305.72 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 7 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,311 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 6,500 | $13.50 | $87,750.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 6 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.35 to $13.71. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 6,500 | $0.51 | $3,315.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 5 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 2,000 | $13.81 | $27,620.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 4 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 2,000 | $2.94 | $5,880.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 3 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 4,900 | $13.81 | $67,669.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 2 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 04, 2021 Filed May 6, 2021 00:15 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 4,900 | $0.46 | $2,254.00 |
DisclosureSEC source: 0001192482-21-000405 · edgar.xml · nonDerivative · entry 1 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 4, 2021 01:05 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 25,000 | $16.02 | $400,500.00 |
DisclosureSEC source: 0001192482-21-000393 · edgar.xml · nonDerivative · entry 4 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 03, 2021 Filed May 4, 2021 01:05 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 25,000 | $14.00 | $350,000.00 |
DisclosureSEC source: 0001192482-21-000393 · edgar.xml · nonDerivative · entry 3 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 575,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 03, 2021 Filed May 4, 2021 01:00 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionOptions (Right to Buy) · Derivative | 195,809 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000391 · edgar.xml · derivative · entry 4 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 737,719 Underlying: Common Stock · 195,809 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 311,176 shares under the option are exercisable. The option, initially representing a right to purchase a total of 933,528 shares, vests and becomes exercisable annually in equal installments over three years commencing on January 2, 2021, subject to continued employment with the Company on the applicable vesting dates. Read SEC document |
| May 03, 2021 Filed May 4, 2021 01:00 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
SaleCommon Stock | 195,809 | $14.24 | $2,788,320.16 |
DisclosureSEC source: 0001192482-21-000391 · edgar.xml · nonDerivative · entry 2 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,000 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.91 to $14.54. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2021 Filed May 4, 2021 01:00 UTC |
Musunuri ShankarDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 195,809 | $0.51 | $99,862.59 |
DisclosureSEC source: 0001192482-21-000391 · edgar.xml · nonDerivative · entry 1 Musunuri Shankar · CIK 0001791820 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 601,809 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 4,317 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · derivative · entry 15 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,900 Underlying: Common Stock · 4,317 shares Expires 2024-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All of the options became exerciable immediately upon grant. Read SEC document |
| May 03, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 4,317 | $16.00 | $69,072.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 10 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| May 03, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 4,317 | $0.46 | $1,985.82 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 9 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,317 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2021 Filed May 6, 2021 00:13 UTC |
Potti ManishDirector
|
SaleCommon Stock | 60,000 | $15.02 | $901,200.00 |
DisclosureSEC source: 0001192482-21-000404 · edgar.xml · nonDerivative · entry 2 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held by Scotland Parkway LLC Disclosed balance after: 63,429 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.10. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · ownership.nature: The Reporting Person is a managing member of Scotland Parkway LLC and has voting and investment power over securities held by Scotland Parkway LLC. Read SEC document |
| May 03, 2021 Filed May 6, 2021 00:13 UTC |
Potti ManishDirector
|
SaleCommon Stock | 28,000 | $15.01 | $420,280.00 |
DisclosureSEC source: 0001192482-21-000404 · edgar.xml · nonDerivative · entry 1 Potti Manish · CIK 0001797537 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.00 to $15.05. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 30, 2021 Filed May 4, 2021 01:05 UTC |
Kompella UdayDirector
|
Exercise / conversionOption (right to buy) · Derivative | 20,000 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000393 · edgar.xml · derivative · entry 6 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,000 Underlying: Common Stock · 20,000 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 24,000 shares under the option are exercisable. The option, initially representing a right to purchase a total of 54,000 shares, vests and becomes exercisable over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| April 30, 2021 Filed May 4, 2021 01:05 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 20,000 | $11.56 | $231,200.00 |
DisclosureSEC source: 0001192482-21-000393 · edgar.xml · nonDerivative · entry 2 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $11.43 to $11.70. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 30, 2021 Filed May 4, 2021 01:05 UTC |
Kompella UdayDirector
|
Exercise / conversionCommon Stock | 20,000 | $0.51 | $10,200.00 |
DisclosureSEC source: 0001192482-21-000393 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620,674 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed May 4, 2021 01:06 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionOption (Right to Buy) · Derivative | 7,990 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001192482-21-000394 · edgar.xml · derivative · entry 3 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,980 Underlying: Common Stock · 7,990 shares Expires 2029-10-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 7,990 shares under the option are exercisable. The option, initially representing a right to purchase a total of 23,970 shares, vests and becomes exercisable in equal annual installments over a three year period. Read SEC document |
| April 29, 2021 Filed May 4, 2021 01:06 UTC |
Subramanian SanjayChief Financial Officer
|
SaleCommon Stock | 7,990 | $10.98 | $87,730.20 |
DisclosureSEC source: 0001192482-21-000394 · edgar.xml · nonDerivative · entry 2 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,591 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.07. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| April 29, 2021 Filed May 4, 2021 01:06 UTC |
Subramanian SanjayChief Financial Officer
|
Exercise / conversionCommon Stock | 7,990 | $2.19 | $17,498.10 |
DisclosureSEC source: 0001192482-21-000394 · edgar.xml · nonDerivative · entry 1 Subramanian Sanjay · CIK 0001790246 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,581 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 5,111 | $0.00 Strike: $0.57 | $0.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · derivative · entry 14 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,889 Underlying: Common Stock · 5,111 shares Expires 2030-08-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: 111,111 shares under the option are exercisable. The option, initially representing a right to purchase a total of 50,000 shares, vests and becomes exercisable over three years commencing on August 14, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 12,880 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · derivative · entry 13 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,761 Underlying: Common Stock · 12,880 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: 34,507 shares under the option are exercisable. The option, initially representing a right to purchase a total of 77,641 shares, vests and becomes exercisable over three years commencing on January 2, 2021, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · derivative · entry 12 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,191 Underlying: Common Stock · 3,000 shares Expires 2026-04-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All of the options became exerciable immediately upon grant. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionOptions (Right to Buy) · Derivative | 9,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · derivative · entry 11 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,217 Underlying: Common Stock · 9,000 shares Expires 2024-09-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: All of the options became exerciable immediately upon grant. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 5,111 | $10.96 | $56,016.56 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 8 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.07. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 5,111 | $0.57 | $2,913.27 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 7 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,111 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 12,880 | $10.96 | $141,164.80 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 6 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.07. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 12,880 | $0.51 | $6,568.80 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 5 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,880 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 3,000 | $10.99 | $32,970.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 4 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionCommon Stock | 3,000 | $2.94 | $8,820.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 3 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
SaleCommon Stock | 9,000 | $10.97 | $98,730.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 2 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.86 to $11.06. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) - (4) to this Form 4. Read SEC document |
| April 29, 2021 Filed May 4, 2021 00:53 UTC |
Tammara VijaySenior Vice President
|
Exercise / conversionComm Stock | 9,000 | $0.46 | $4,140.00 |
DisclosureSEC source: 0001192482-21-000388 · edgar.xml · nonDerivative · entry 1 Tammara Vijay · CIK 0001791822 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 26, 2021 Filed Apr 28, 2021 22:52 UTC |
Kompella UdayDirector
|
SaleCommon Stock | 350,000 | $11.70 | $4,095,000.00 |
DisclosureSEC source: 0001192482-21-000371 · edgar.xml · nonDerivative · entry 1 Kompella Uday · CIK 0001791821 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,674 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.8300 to $12.5400. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:16 UTC |
Kumar RameshDirector
|
Exercise / conversionOption (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $0.51 | $0.00 |
DisclosureSEC source: 0001192482-21-000346 · edgar.xml · derivative · entry 3 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,500 Underlying: Common Stock · 7,500 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested monthly in equal installments over three years commencing on February 2, 2020, subject to continued service with the Company on the applicable vesting dates. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:16 UTC |
Kumar RameshDirector
|
SaleCommon Stock | 7,500 | $5.33 | $39,975.00 |
DisclosureSEC source: 0001192482-21-000346 · edgar.xml · nonDerivative · entry 2 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: This sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $5.29 to $5.37. Read SEC document |
| April 19, 2021 Filed Apr 21, 2021 20:16 UTC |
Kumar RameshDirector
|
Exercise / conversionCommon Stock | 7,500 | $0.51 | $3,825.00 |
DisclosureSEC source: 0001192482-21-000346 · edgar.xml · nonDerivative · entry 1 Kumar Ramesh · CIK 0001580074 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.